Revolution Medicines (RVMD) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$189.76
+0.9% on the day
+298.5% over 12 months
52-week range $47.50 – $221.15
Share price and insider trades
RVMD closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$157M
Insiders buying0
Insiders selling12
Revolution Medicines insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 12 sold $157M of RVMD stock on the open market.
Get emailed when insiders cluster-buy stocks like RVMD
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
RVMD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $78.0M | 79 |
| Q2 2026 | — | 0 | $42.9M | 34 |
| Q1 2026 | — | 0 | $19.0M | 31 |
| Q4 2025 | — | 0 | $16.8M | 18 |
| Q3 2025 | — | 0 | — | 0 |
| Q2 2025 | — | 0 | $558K | 1 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Revolution Medicines, Inc. insiders reported open-market purchases totaling $0, while 12 insiders reported sales totaling $157M. 162 of 163 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 1SEC | Alan B. SandlerChief Development Officer | Sell Plan | 2,20056,668 held (−4%) | $200.82 | $442K | -5.5% | — |
| Oct 1SEC | Alan B. SandlerChief Development Officer | Sell Plan | 1,60955,059 held (−3%) | $201.72 | $325K | -5.9% | — |
| Oct 1SEC | Alan B. SandlerChief Development Officer | Sell Plan | 1,19952,860 held (−2%) | $203.91 | $244K | -6.9% | — |
| Oct 1SEC | Alan B. SandlerChief Development Officer | Sell Plan | 1,00054,059 held (−2%) | $202.81 | $203K | -6.4% | — |
| Oct 1SEC | Alan B. SandlerChief Development Officer | Sell Plan | 30152,559 held (−1%) | $204.72 | $62K | -7.3% | — |
| Sep 29SEC | Jeff CisliniGeneral Counsel | Sell Plan | 76551,776 held (−1%) | $207.32 | $159K | -8.5% | — |
| Sep 28SEC | Anthony ManciniSee Remarks | Sell Plan | 3,12139,765 held (−7%) | $200.54 | $626K | -5.4% | — |
| Sep 28SEC | Anthony ManciniSee Remarks | Sell Plan | 58739,765 held (−1%) | $200.00 | $117K | -5.1% | — |
| Sep 24SEC | Elizabeth M AndersonDirector | Sell Plan | 4,9858,581 held (−37%) | $192.54 | $960K | -1.4% | — |
| Sep 24SEC | Elizabeth M AndersonDirector | Sell Plan | 2,6485,933 held (−31%) | $193.44 | $512K | -1.9% | — |
| Sep 24SEC | Elizabeth M AndersonDirector | Sell Plan | 1,5004,433 held (−25%) | $194.59 | $292K | -2.5% | — |
| Sep 24SEC | Elizabeth M AndersonDirector | Sell Plan | 91013,566 held (−6%) | $191.85 | $175K | -1.1% | — |
| Sep 24SEC | Elizabeth M AndersonDirector | Sell Plan | 1004,333 held (−2%) | $195.15 | $20K | -2.8% | — |
| Sep 22SEC | Anthony ManciniSee Remarks | Sell Plan | 1,76440,352 held (−4%) | $196.94 | $347K | -3.6% | — |
| Sep 18SEC | Mark A GoldsmithSee Remarks | Sell Plan | 13,775253,342 held (−5%) | $199.30 | $2.7M | -4.8% | — |
| Sep 18SEC | Stephen Michael KelseySee Remarks | Sell Plan | 5,484286,307 held (−2%) | $199.30 | $1.1M | -4.8% | — |
| Sep 18SEC | Margaret A HornCOO | Sell Plan | 4,891149,680 held (−3%) | $199.30 | $975K | -4.8% | — |
| Sep 18SEC | Jack AndersCFO | Sell Plan | 3,992119,216 held (−3%) | $199.30 | $796K | -4.8% | — |
| Sep 18SEC | Jeff CisliniGeneral Counsel | Sell Plan | 3,31452,541 held (−6%) | $199.30 | $660K | -4.8% | — |
| Sep 18SEC | Anthony ManciniSee Remarks | Sell Plan | 1,74742,116 held (−4%) | $199.30 | $348K | -4.8% | — |
| Sep 18SEC | Alan B. SandlerChief Development Officer | Sell Plan | 33652,868 held (−1%) | $199.30 | $67K | -4.8% | — |
| Sep 18SEC | Mark A GoldsmithSee Remarks | Sell Plan | 213267,117 held (−0%) | $195.01 | $42K | -2.7% | — |
| Sep 18SEC | Stephen Michael KelseySee Remarks | Sell Plan | 85291,791 held (−0%) | $195.01 | $17K | -2.7% | — |
| Sep 18SEC | Margaret A HornCOO | Sell Plan | 76154,571 held (−0%) | $195.01 | $15K | -2.7% | — |
| Sep 18SEC | Jack AndersCFO | Sell Plan | 61123,208 held (−0%) | $195.00 | $12K | -2.7% | — |
| Sep 18SEC | Jeff CisliniGeneral Counsel | Sell Plan | 5255,855 held (−0%) | $195.01 | $10K | -2.7% | — |
| Sep 18SEC | Anthony ManciniSee Remarks | Sell Plan | 2743,863 held (−0%) | $195.05 | $5K | -2.7% | — |
| Sep 18SEC | Alan B. SandlerChief Development Officer | Sell Plan | 553,204 held (−0%) | $194.96 | $975 | -2.7% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 21,447336,959 held (−6%) | $201.75 | $4.3M | -5.9% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 18,869318,090 held (−6%) | $203.06 | $3.8M | -6.5% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 17,949300,141 held (−6%) | $203.87 | $3.7M | -6.9% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 13,368358,406 held (−4%) | $200.78 | $2.7M | -5.5% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 11,833371,774 held (−3%) | $200.11 | $2.4M | -5.2% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 4,995295,146 held (−2%) | $204.84 | $1.0M | -7.4% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 3,270291,876 held (−1%) | $205.81 | $673K | -7.8% | — |
| Sep 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 800383,607 held (−0%) | $198.55 | $159K | -4.4% | — |
| Sep 14SEC | Anthony ManciniSee Remarks | Sell Plan | 6,01953,319 held (−10%) | $203.28 | $1.2M | -6.7% | — |
| Sep 14SEC | Anthony ManciniSee Remarks | Sell Plan | 5,53047,789 held (−10%) | $204.14 | $1.1M | -7.0% | — |
| Sep 14SEC | Anthony ManciniSee Remarks | Sell Plan | 2,42045,369 held (−5%) | $205.05 | $496K | -7.5% | — |
| Sep 14SEC | Anthony ManciniSee Remarks | Sell Plan | 1,17944,190 held (−3%) | $206.10 | $243K | -7.9% | — |
| Sep 14SEC | Anthony ManciniSee Remarks | Sell Plan | 30043,890 held (−1%) | $207.17 | $62K | -8.4% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 4,7304,215 held (−53%) | $210.50 | $996K | -9.9% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 3,844371 held (−91%) | $211.36 | $812K | -10.2% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 3,58711,798 held (−23%) | $208.55 | $748K | -9.0% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 2,8538,945 held (−24%) | $209.56 | $598K | -9.4% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 99915,385 held (−6%) | $207.33 | $207K | -8.5% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 70616,384 held (−4%) | $206.60 | $146K | -8.2% | — |
| Sep 10SEC | Lorence H. KimDirector | Sell Plan | 371 | $212.27 | $79K | -10.6% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 26,16027,114 held (−49%) | $203.55 | $5.3M | -6.8% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 12,91953,274 held (−20%) | $202.48 | $2.6M | -6.3% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 7,27119,843 held (−27%) | $204.35 | $1.5M | -7.1% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 6,59766,193 held (−9%) | $201.47 | $1.3M | -5.8% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 2,12817,715 held (−11%) | $205.19 | $437K | -7.5% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 62517,090 held (−4%) | $206.15 | $129K | -8.0% | — |
| Sep 2SEC | Lorence H. KimDirector | Sell Plan | 30072,790 held (−0%) | $200.56 | $60K | -5.4% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 35,938281,347 held (−11%) | $209.26 | $7.5M | -9.3% | — |
| Aug 25SEC | Jeff CisliniGeneral Counsel | Sell Plan | 25,81766,261 held (−28%) | $209.25 | $5.4M | -9.3% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 24,917317,285 held (−7%) | $208.37 | $5.2M | -8.9% | — |
| Aug 25SEC | Jeff CisliniGeneral Counsel | Sell Plan | 17,32392,078 held (−16%) | $208.37 | $3.6M | -8.9% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 6,583270,951 held (−2%) | $211.33 | $1.4M | -10.2% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 5,128342,202 held (−1%) | $207.23 | $1.1M | -8.4% | — |
| Aug 25SEC | Jeff CisliniGeneral Counsel | Sell Plan | 4,50059,221 held (−7%) | $211.34 | $951K | -10.2% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 3,813277,534 held (−1%) | $210.25 | $802K | -9.7% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 3,621267,330 held (−1%) | $212.08 | $768K | -10.5% | — |
| Aug 25SEC | Jeff CisliniGeneral Counsel | Sell Plan | 3,400109,401 held (−3%) | $207.24 | $705K | -8.4% | — |
| Aug 25SEC | Jeff CisliniGeneral Counsel | Sell Plan | 3,31455,907 held (−6%) | $212.06 | $703K | -10.5% | — |
| Aug 25SEC | Jeff CisliniGeneral Counsel | Sell Plan | 2,54063,721 held (−4%) | $210.26 | $534K | -9.7% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 1,40561,905 held (−2%) | $209.27 | $294K | -9.3% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 1,35161,932 held (−2%) | $209.28 | $283K | -9.3% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 95163,283 held (−1%) | $208.36 | $198K | -8.9% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 93763,310 held (−1%) | $208.36 | $195K | -8.9% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 24561,551 held (−0%) | $211.47 | $52K | -10.3% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 22961,550 held (−0%) | $211.46 | $48K | -10.3% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 19064,234 held (−0%) | $207.25 | $39K | -8.4% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 17764,247 held (−0%) | $207.25 | $37K | -8.4% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 13661,796 held (−0%) | $210.40 | $29K | -9.8% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 12761,424 held (−0%) | $212.06 | $27K | -10.5% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 12661,424 held (−0%) | $212.06 | $27K | -10.5% | — |
| Aug 25SEC | Mark A GoldsmithSee Remarks | Sell Plan | 12661,779 held (−0%) | $210.40 | $27K | -9.8% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 1,10024,936 held (−4%) | $185.90 | $204K | +2.1% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 88121,656 held (−4%) | $192.61 | $170K | -1.5% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 90026,036 held (−3%) | $184.59 | $166K | +2.8% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 85824,078 held (−3%) | $186.92 | $160K | +1.5% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 60023,078 held (−3%) | $190.55 | $114K | -0.4% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 54122,537 held (−2%) | $191.87 | $104K | -1.1% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 30023,778 held (−1%) | $187.83 | $56K | +1.0% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 30026,936 held (−1%) | $183.17 | $55K | +3.6% | — |
| Jul 1SEC | Sushil PatelDirector | Sell Plan | 10023,678 held (−0%) | $188.57 | $19K | +0.6% | — |
| Jun 26SEC | Jack AndersCFO | Sell Plan | 9,496129,220 held (−7%) | $168.20 | $1.6M | +12.8% | — |
| Jun 26SEC | Jack AndersCFO | Sell Plan | 5,651123,569 held (−4%) | $169.24 | $956K | +12.1% | — |
| Jun 26SEC | Jack AndersCFO | Sell Plan | 4,553138,716 held (−3%) | $167.35 | $762K | +13.4% | — |
| Jun 26SEC | Jack AndersCFO | Sell Plan | 300123,269 held (−0%) | $170.32 | $51K | +11.4% | — |
| Jun 18SEC | Mark A GoldsmithSee Remarks | Sell Plan | 10,020267,330 held (−4%) | $156.12 | $1.6M | +21.5% | — |
| Jun 18SEC | Anthony ManciniSee Remarks | Sell | 4,61549,975 held (−8%) | $156.12 | $720K | +21.5% | — |
| Jun 18SEC | Stephen Michael KelseySee Remarks | Sell Plan | 4,175291,876 held (−1%) | $156.12 | $652K | +21.5% | — |
| Jun 18SEC | Jack AndersCFO | Sell Plan | 2,722123,269 held (−2%) | $156.12 | $425K | +21.5% | — |
| Jun 18SEC | Jeff CisliniGeneral Counsel | Sell Plan | 2,15756,521 held (−4%) | $156.12 | $337K | +21.5% | — |
| Jun 17SEC | Margaret A HornCOO | Sell Plan | 60,400158,222 held (−28%) | $160.17 | $9.7M | +18.5% | — |
| Jun 17SEC | Margaret A HornCOO | Sell Plan | 29,600154,647 held (−16%) | $160.12 | $4.7M | +18.5% | — |
| Jun 17SEC | Margaret A HornCOO | Sell Plan | 3,575154,647 held (−2%) | $156.12 | $558K | +21.5% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 4,600158,422 held (−3%) | $149.64 | $688K | +26.8% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 1,800163,022 held (−1%) | $148.72 | $268K | +27.6% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 1,315166,907 held (−1%) | $144.28 | $190K | +31.5% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 885166,022 held (−1%) | $145.15 | $128K | +30.7% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 700165,322 held (−0%) | $146.04 | $102K | +29.9% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 500164,822 held (−0%) | $147.27 | $74K | +28.9% | — |
| Jun 15SEC | Margaret A HornCOO | Sell Plan | 200158,222 held (−0%) | $150.17 | $30K | +26.4% | — |
| May 28SEC | Anthony ManciniSee Remarks | Sell Plan | 2,00054,821 held (−4%) | $154.06 | $308K | +23.2% | — |
| May 28SEC | Anthony ManciniSee Remarks | Sell Plan | 70056,821 held (−1%) | $153.30 | $107K | +23.8% | — |
| May 28SEC | Anthony ManciniSee Remarks | Sell Plan | 42154,400 held (−1%) | $154.82 | $65K | +22.6% | — |
| Apr 29SEC | Anthony ManciniSee Remarks | Sell Plan | 1,67155,849 held (−3%) | $131.66 | $220K | +44.1% | — |
| Apr 29SEC | Anthony ManciniSee Remarks | Sell Plan | 1,04954,800 held (−2%) | $132.88 | $139K | +42.8% | — |
| Apr 29SEC | Anthony ManciniSee Remarks | Sell Plan | 40054,400 held (−1%) | $134.34 | $54K | +41.3% | — |
| Apr 17SEC | Mark A GoldsmithSee Remarks | Sell Plan | 120,000276,698 held (−30%) | $150.09 | $18.0M | +26.4% | — |
| Mar 26SEC | Anthony ManciniSee Remarks | Sell Plan | 21,08665,836 held (−24%) | $95.49 | $2.0M | +98.7% | — |
| Mar 26SEC | Anthony ManciniSee Remarks | Sell Plan | 11,03654,800 held (−17%) | $96.43 | $1.1M | +96.8% | — |
| Mar 26SEC | Anthony ManciniSee Remarks | Sell Plan | 3,12886,922 held (−3%) | $94.16 | $295K | +101.5% | — |
| Mar 26SEC | Anthony ManciniSee Remarks | Sell Plan | 1,80090,050 held (−2%) | $93.22 | $168K | +103.6% | — |
| Mar 26SEC | Anthony ManciniSee Remarks | Sell Plan | 40054,400 held (−1%) | $97.21 | $39K | +95.2% | — |
| Mar 19SEC | Mark A GoldsmithSee Remarks | Sell Plan | 12,871276,698 held (−4%) | $99.48 | $1.3M | +90.8% | — |
| Mar 19SEC | Margaret A HornCOO | Sell Plan | 4,583157,570 held (−3%) | $99.48 | $456K | +90.8% | — |
| Mar 19SEC | Stephen Michael KelseySee Remarks | Sell Plan | 4,302295,398 held (−1%) | $99.48 | $428K | +90.8% | — |
| Mar 19SEC | Jack AndersCFO | Sell Plan | 2,753125,512 held (−2%) | $99.48 | $274K | +90.8% | — |
| Mar 19SEC | Lin WeiChief Medical Officer | Sell Plan | 2,073101,366 held (−2%) | $99.48 | $206K | +90.8% | — |
| Mar 19SEC | Xiaolin WangSee Remarks | Sell Plan | 2,010116,063 held (−2%) | $99.48 | $200K | +90.8% | — |
| Mar 19SEC | Jeff CisliniGeneral Counsel | Sell Plan | 1,79559,681 held (−3%) | $99.48 | $179K | +90.8% | — |
| Mar 19SEC | Jeff CisliniGeneral Counsel | Sell Plan | 1,16358,518 held (−2%) | $97.44 | $113K | +94.7% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 21,329290,420 held (−7%) | $101.60 | $2.2M | +86.8% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 3,620311,749 held (−1%) | $100.73 | $365K | +88.4% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 3,500315,369 held (−1%) | $99.76 | $349K | +90.2% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 2,10064,624 held (−3%) | $101.63 | $213K | +86.7% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 1,70065,224 held (−3%) | $101.47 | $172K | +87.0% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 851289,569 held (−0%) | $102.20 | $87K | +85.7% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 80064,424 held (−1%) | $102.00 | $82K | +86.0% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 700318,869 held (−0%) | $98.17 | $69K | +93.3% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 60066,724 held (−1%) | $100.19 | $60K | +89.4% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 40066,924 held (−1%) | $100.12 | $40K | +89.5% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 20064,424 held (−0%) | $102.08 | $20K | +85.9% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 10067,324 held (−0%) | $98.31 | $10K | +93.0% | — |
| Mar 3SEC | Mark A GoldsmithSee Remarks | Sell Plan | 10067,324 held (−0%) | $98.29 | $10K | +93.1% | — |
| Jan 23SEC | Jeff CisliniGeneral Counsel | Sell Plan | 90846,976 held (−2%) | $115.60 | $105K | +64.2% | — |
| Jan 9SEC | Margaret A HornCOO | Sell Plan | 53,096162,957 held (−25%) | $100.02 | $5.3M | +89.7% | — |
| Jan 9SEC | Margaret A HornCOO | Sell Plan | 20,204142,753 held (−12%) | $101.79 | $2.1M | +86.4% | — |
| Jan 9SEC | Jack AndersCFO | Sell Plan | 10,000108,065 held (−8%) | $98.00 | $980K | +93.6% | — |
| Jan 9SEC | Margaret A HornCOO | Sell Plan | 1,700141,053 held (−1%) | $102.90 | $175K | +84.4% | — |
| Dec 18SEC | Mark A GoldsmithSee Remarks | Sell Plan | 15,394232,469 held (−6%) | $76.82 | $1.2M | +147.0% | — |
| Dec 18SEC | Stephen Michael KelseySee Remarks | Sell Plan | 5,447278,600 held (−2%) | $76.82 | $418K | +147.0% | — |
| Dec 18SEC | Margaret A HornCOO | Sell Plan | 4,847141,053 held (−3%) | $76.82 | $372K | +147.0% | — |
| Dec 18SEC | Jack AndersCFO | Sell Plan | 3,104108,065 held (−3%) | $77.09 | $239K | +146.2% | — |
| Dec 18SEC | Jeff CisliniGeneral Counsel | Sell Plan | 2,68847,884 held (−5%) | $76.82 | $206K | +147.0% | — |
| Nov 26SEC | Mark A GoldsmithSee Remarks | Sell Plan | 60,000247,863 held (−19%) | $75.08 | $4.5M | +152.7% | — |
| Nov 26SEC | Jack AndersCFO | Sell Plan | 5,418110,994 held (−5%) | $74.00 | $401K | +156.4% | — |
| Nov 26SEC | Mark A GoldsmithSee Remarks | Sell Plan | 3,00067,424 held (−4%) | $75.00 | $225K | +153.0% | — |
| Nov 26SEC | Mark A GoldsmithSee Remarks | Sell Plan | 3,00067,424 held (−4%) | $75.00 | $225K | +153.0% | — |
| Nov 20SEC | Mark A GoldsmithSee Remarks | Sell Plan | 20,000247,863 held (−7%) | $70.38 | $1.4M | +169.6% | — |
| Nov 20SEC | Jeff CisliniGeneral Counsel | Sell Plan | 13,38850,425 held (−21%) | $70.14 | $939K | +170.5% | — |
| Nov 14SEC | Mark A GoldsmithSee Remarks | Sell Plan | 20,000247,863 held (−7%) | $65.07 | $1.3M | +191.6% | — |
| Nov 13SEC | Jack AndersCFO | Sell Plan | 10,000110,994 held (−8%) | $64.00 | $640K | +196.5% | — |
| Nov 12SEC | Mark A GoldsmithSee Remarks | Sell Plan | 30,000347,863 held (−8%) | $60.31 | $1.8M | +214.6% | — |
| Oct 20SEC | Jeff CisliniGeneral Counsel | Sell Plan | 12,00050,425 held (−19%) | $55.00 | $660K | +245.0% | — |
| Oct 20SEC | Mark A GoldsmithSee Remarks | Sell Plan | 10,000452,309 held (−2%) | $55.00 | $550K | +245.0% | — |
| Oct 20SEC | Mark A GoldsmithSee Remarks | Sell Plan | 10,000452,309 held (−2%) | $50.47 | $505K | +276.0% | — |
| Oct 15SEC | Stephen Michael KelseySee Remarks | Sell Plan | 25,000284,047 held (−8%) | $48.54 | $1.2M | +290.9% | — |
Insiders at Revolution Medicines, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Mark A GoldsmithSee Remarks | — | $57.0M | Sep 18, 2026 | — |
| Margaret A HornCOO | — | $25.8M | Sep 18, 2026 | — |
| Stephen Michael KelseySee Remarks | — | $22.5M | Sep 18, 2026 | — |
| Jeff CisliniGeneral Counsel | — | $15.3M | Sep 29, 2026 | — |
| Lorence H. KimDirector | — | $15.0M | Sep 10, 2026 | — |
| Anthony ManciniSee Remarks | — | $9.8M | Sep 28, 2026 | — |
| Jack AndersCFO | — | $7.1M | Sep 18, 2026 | — |
| Elizabeth M AndersonDirector | — | $2.0M | Sep 24, 2026 | — |
| Alan B. SandlerChief Development Officer | — | $1.3M | Oct 1, 2026 | — |
| Sushil PatelDirector | — | $1.0M | Jul 1, 2026 | — |
| Lin WeiChief Medical Officer | — | $206K | Mar 19, 2026 | — |
| Xiaolin WangSee Remarks | — | $200K | Mar 19, 2026 | — |
RVMD stock: common questions
Are Revolution Medicines, Inc. insiders buying RVMD stock?
In the past 12 months, 0 insiders reported open-market purchases of RVMD worth $0.
Are Revolution Medicines, Inc. insiders selling RVMD stock?
12 insiders reported sales worth $157M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is RVMD's 52-week range?
Over the past year RVMD has traded between $47.50 and $221.15. It last closed at $189.76 on Oct 9, 2026.